Sirios Capital Management L P Eli Lilly & CO Transaction History

Sirios Capital Management L P

$493 Million
Q3 2024

A detailed history of Sirios Capital Management L P transactions in Eli Lilly & CO stock. As of the latest transaction made, Sirios Capital Management L P holds 15,840 shares of LLY stock, worth $12.6 Million. This represents 2.85% of its overall portfolio holdings.

Number of Shares

15,840

Previous 19,214 17.56%

Holding current value

$12.6 Million

Previous $17.4 Million 19.33%

% of portfolio

2.85%

Previous 3.33%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $2.61 Million - $3.24 Million	-3,374 Reduced 17.56%	15,840 $14 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $188,466 - $236,350	-260 Reduced 1.34%	19,214 $17.4 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $5.68 Million - $7.61 Million	-9,599 Reduced 33.02%	19,474 $15.1 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $2.53 Million - $2.98 Million	-4,816 Reduced 14.21%	29,073 $16.9 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $1.08 Million - $1.48 Million	-2,475 Reduced 6.81%	33,889 $18.2 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $788,112 - $1.05 Million	-2,247 Reduced 5.82%	36,364 $17.1 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $442,337 - $519,503	-1,424 Reduced 3.56%	38,611 $13.3 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $3.16 Million - $3.68 Million	-9,829 Reduced 19.71%	40,035 $14.6 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $1.32 Million - $1.5 Million	-4,438 Reduced 8.17%	49,864 $16.1 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $420,324 - $493,523	-1,508 Reduced 2.7%	54,302 $17.6 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $7.15 Million - $8.88 Million	-30,451 Reduced 35.3%	55,810 $16 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $1.6 Million - $1.98 Million	-7,098 Reduced 7.6%	86,261 $23.8 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $3.26 Million - $4.02 Million	-14,723 Reduced 13.62%	93,359 $21.6 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $13.5 Million - $17.4 Million	-74,693 Reduced 40.87%	108,082 $24.8 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $9.75 Million - $12.6 Million	-59,345 Reduced 24.51%	182,775 $34.1 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $7.95 Million - $10.5 Million	-60,931 Reduced 20.11%	242,120 $40.9 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $44.3 Million - $51.3 Million	303,051 New	303,051 $44.9 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sirios Capital Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Sirios Capital Management L P with notifications on news.

Account

Sirios Capital Management L P Eli Lilly & CO Transaction History